Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Guided Therapeutics (GTHP) Interest Income - Total (2023 - 2024)

Guided Therapeutics' Interest Income - Total history spans 2 years, with the latest figure at $3000.0 for Q1 2024.

  • For Q1 2024, Interest Income - Total changed N/A year-over-year to $3000.0; the TTM value through Dec 2024 reached $3000.0, down 50.0%, while the annual FY2024 figure was $3000.0, 50.0% down from the prior year.
  • Interest Income - Total for Q1 2024 was $3000.0 at Guided Therapeutics, down from $6000.0 in the prior quarter.
  • Across five years, Interest Income - Total topped out at $6000.0 in Q4 2023 and bottomed at $3000.0 in Q1 2024.